| scholarly article | Q13442814 |
| P50 | author | Michael A. Fischbach | Q22004359 |
| Marvin J Fritzler | Q63302292 | ||
| John D Reveille | Q67485113 | ||
| P2093 | author name string | Maureen D Mayes | |
| Sanjay Shete | |||
| Filemon K Tan | |||
| Frank C Arnett | |||
| Pravitt Gourh | |||
| Sandeep K Agarwal | |||
| Terry McNearney | |||
| Chul W Ahn | |||
| Robert E Honey | |||
| P2860 | cites work | Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 |
| Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis | Q28276277 | ||
| Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus | Q28301821 | ||
| Major histocompatibility complex class II genes and systemic sclerosis | Q33631741 | ||
| Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody | Q33855883 | ||
| The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosis | Q34109161 | ||
| Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis | Q34287872 | ||
| Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype | Q34388421 | ||
| Immunogenetic basis of environmental lung disease: lessons from the berylliosis model | Q34486057 | ||
| Scleroderma epidemiology | Q34535093 | ||
| Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma) | Q35600647 | ||
| Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis) | Q35822079 | ||
| HLA markers for susceptibility and expression in scleroderma | Q36217633 | ||
| Systemic sclerosis: hypothesis-driven treatment strategies | Q36484155 | ||
| Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee | Q39513167 | ||
| Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants | Q39563893 | ||
| HLA and Autoimmunity in Scleroderma (Systemic Sclerosis) | Q40468509 | ||
| HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma). | Q41471335 | ||
| Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies | Q42603143 | ||
| Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. | Q43630758 | ||
| HLA dictionary 2004: summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens | Q48712077 | ||
| The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. | Q51768945 | ||
| An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. | Q53550973 | ||
| The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl | Q57089713 | ||
| Association between theIRF5rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis | Q57613023 | ||
| The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis | Q57753621 | ||
| Severe systemic sclerosis with anti-topoisomerase I Antibodies is associated with an HLA-DRw11 allele | Q62748731 | ||
| HLA-DPB1 alleles and autoantibody subsets in systemic lupus erythematosus, Sjögren's syndrome and progressive systemic sclerosis: a question of disease relevance | Q67585259 | ||
| Scleroderma (systemic sclerosis): classification, subsets and pathogenesis | Q68330753 | ||
| Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis | Q71160324 | ||
| Increased frequency of HLA-DR5 in scleroderma | Q72091069 | ||
| The HLA-DP locus in systemic sclerosis--no primary association | Q72716024 | ||
| HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian men | Q73028022 | ||
| Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin) | Q73797347 | ||
| Association of HLA class II genes with systemic sclerosis in Koreans | Q74254578 | ||
| HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients | Q74502807 | ||
| Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis | Q77852708 | ||
| Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population | Q78794905 | ||
| HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities | Q79368458 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 822-827 | |
| P577 | publication date | 2009-07-12 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls | |
| P478 | volume | 69 |
| Q40982238 | Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis. |
| Q51476905 | Angiotensin II Type 1 receptor (AGTR1) gene polymorphisms are associated with vascular manifestations in patients with systemic sclerosis (SSc). |
| Q36129874 | Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus |
| Q35146164 | Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis |
| Q35661256 | Antinuclear antibody-negative systemic sclerosis |
| Q37538699 | Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population |
| Q37460601 | Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population |
| Q40091942 | Association of HLA-DRB1*15:02 and DRB5*01:02 allele with the susceptibility to systemic sclerosis in Thai patients |
| Q34129114 | Association of the HLA-DRB1 with scleroderma in Chinese population |
| Q47446383 | Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese |
| Q34684413 | Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis |
| Q33886453 | Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis |
| Q37806663 | Biomarkers in the management of scleroderma: an update |
| Q46463646 | Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis |
| Q59192506 | Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans |
| Q37686401 | Characterization of the HLA-DRβ1 third hypervariable region amino acid sequence according to charge and parental inheritance in systemic sclerosis |
| Q33903786 | Clinical and genetic factors predictive of mortality in early systemic sclerosis |
| Q49486890 | Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database |
| Q34186473 | Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis |
| Q34277474 | Comparing HLA shared epitopes in French Caucasian patients with scleroderma |
| Q37460616 | Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study |
| Q38364957 | Current frontiers in systemic sclerosis pathogenesis. |
| Q26741264 | Current perspectives on the immunopathogenesis of systemic sclerosis |
| Q37905783 | Deciphering the genetic background of systemic sclerosis |
| Q35617691 | Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts |
| Q90257760 | Definition of naturally processed peptides reveals convergent presentation of autoantigenic topoisomerase-I epitopes in scleroderma |
| Q46397634 | Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients |
| Q92003078 | Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease |
| Q36063970 | Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic Sclerosis |
| Q52660415 | Frank Stinchfield Award: Identification of the At-risk Genotype for Development of Pseudotumors Around Metal-on-metal THAs. |
| Q36871425 | Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma |
| Q35649228 | Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight). |
| Q34545752 | Genetics of scleroderma: implications for personalized medicine? |
| Q38511454 | Genetics of systemic sclerosis. |
| Q26799577 | Genetics, Epigenetics, and Genomics of Systemic Sclerosis |
| Q24630434 | Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus |
| Q30388977 | Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia |
| Q21144954 | Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis |
| Q35629254 | HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients. |
| Q92217574 | HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry |
| Q37176585 | HLA markers for poor prognosis in systemic sclerosis Brazilian patients. |
| Q34625202 | HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis |
| Q35999755 | Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01. |
| Q36012302 | Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up |
| Q36619876 | Identification of an Association of TNFAIP3 Polymorphisms With Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associated Genetic and Environmental Factors |
| Q29417020 | Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy |
| Q37441841 | Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis |
| Q90556754 | Increased Mortality in Asians With Systemic Sclerosis in Northern California |
| Q42014200 | Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. |
| Q61444377 | Interactions of HLA-DR and Topoisomerase I Epitope Modulated Genetic Risk for Systemic Sclerosis |
| Q47372819 | Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review |
| Q34318888 | Lack of Association of the CD247 SNP rs2056626 with Systemic Sclerosis in Han Chinese |
| Q34415750 | Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort |
| Q48502389 | Moving towards a molecular taxonomy of autoimmune rheumatic diseases |
| Q57285544 | New insights into the genetics and epigenetics of systemic sclerosis |
| Q24645988 | Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis |
| Q35693212 | Pathogenesis of Systemic Sclerosis |
| Q33945954 | Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine |
| Q35609106 | Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. |
| Q90061456 | Pro-fibrotic Activation of Human Macrophages in Systemic Sclerosis |
| Q58122062 | Regulatory T Cells in Systemic Sclerosis |
| Q37852786 | Shared genetics in coeliac disease and other immune-mediated diseases |
| Q38092053 | Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. |
| Q41066068 | Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis. |
| Q93160109 | Systemic Sclerosis is Linked to Psoriasis and May Impact on Patients' Survival: A Large Cohort Study |
| Q41826432 | Systemic Sclerosis is a Complex Disease Associated Mainly with Immune Regulatory and Inflammatory Genes |
| Q41863950 | The Vascular Microenvironment and Systemic Sclerosis |
| Q37801569 | The genetics of scleroderma |
| Q36918205 | The genetics of scleroderma: looking into the postgenomic era |
| Q84970446 | The genetics of systemic sclerosis |
| Q50111176 | The prevalence of HLA alleles in a lupus nephritis population. |
| Q30241539 | The role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases. |
| Q38543690 | The role of the acquired immune response in systemic sclerosis |
| Q38681645 | Unfolding the pathogenesis of scleroderma through genomics and epigenomics |
| Q37973287 | Unraveling the genetic component of systemic sclerosis |
| Q38183300 | Update on etiopathogenesis of systemic sclerosis |
| Q35557424 | Vascular involvement in systemic sclerosis (scleroderma). |
Search more.